UBS AM’s Core Scientific CORZ Stock Holding History

UBS AM’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Buy	415,569 +9,935	+2%	+$234K	﹤0.01%	1212
2026 Q1	$6.07M	Sell	405,634 -41,431	-9%	-$707K	﹤0.01%	1473
2025 Q4	$6.51M	Sell	447,065 -17,486	-4%	-$305K	﹤0.01%	1327
2025 Q3	$8.33M	Sell	464,551 -324,678	-41%	-$4.76M	﹤0.01%	1135
2025 Q2	$13.5M	Sell	789,229 -320,158	-29%	-$3.2M	﹤0.01%	1211
2025 Q1	$8.03M	Buy	1,109,387 +714,388	+181%	+$8.13M	﹤0.01%	1332
2024 Q4	$5.55M	Buy	394,999 +171,461	+77%	+$2.53M	﹤0.01%	1555
2024 Q3	$2.65M	Buy	+223,538	New	+$2.32M	﹤0.01%	1896

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

UBS AM's CORZ Position: Q2 2026 in Review

UBS AM increased its Core Scientific (CORZ) stake by 2.4% in Q2 2026, buying an estimated $234K and bringing the position to 415,569 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

UBS AM first reported a position in CORZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.5M in Q2 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

UBS AM held 415,569 shares of Core Scientific worth $10.6M as of Q2 2026.
UBS AM bought 9,935 Core Scientific shares in Q2 2026, an estimated $234K.
Core Scientific made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1212 holding.
UBS AM first reported a position in Core Scientific in Q3 2024 and has held it in 8 quarters since.
UBS AM's Core Scientific position peaked at $13.5M in Q2 2025.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.